Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis.

PubWeight™: 2.06‹?› | Rank: Top 2%

🔗 View Article (PMID 6019764)

Published in N Engl J Med on March 09, 1967

Authors

C L Hampers, R Streiff, D G Nathan, D Snyder, J P Merrill

Articles by these authors

Positive and negative elements regulate human interleukin 3 expression. Proc Natl Acad Sci U S A (1990) 7.44

Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med (1968) 6.91

Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med (1994) 5.32

Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature (1984) 5.10

Why Americans eat what they do: taste, nutrition, cost, convenience, and weight control concerns as influences on food consumption. J Am Diet Assoc (1998) 4.65

Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion. N Engl J Med (1978) 4.34

Leukocyte oxidase: defective activity in chronic granulomatous disease. Science (1967) 4.25

Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med (1996) 3.01

Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med (1968) 2.70

Globin chain synthesis in the alpha thalassemia syndromes. J Clin Invest (1969) 2.46

Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med (1970) 2.43

Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest (1984) 2.43

The molecular basis of alpha-thalassemias: frequent occurrence of dysfunctional alpha loci among non-Asians with Hb H disease. Cell (1979) 2.41

Treatment of Cooley's anemia. Blood (1990) 2.40

Disorders of phagocytic cell function. Prog Hematol (1971) 2.37

Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature (1986) 2.36

Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro. J Exp Med (1978) 2.33

Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33

Continuous subcutaenous administration of deferoxamine in patients with iron overload. N Engl J Med (1977) 2.31

Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29

Intrarenal distribution of blood flow in the transplanted dog kidney: effect of denervation and rejection. J Clin Invest (1967) 2.14

Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines. Blood (1989) 2.13

Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. J Clin Invest (1969) 2.11

Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease. J Clin Invest (1970) 2.04

Thalassemia: the consequences of unbalanced hemoglobin synthesis. Am J Med (1966) 2.03

Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc Natl Acad Sci U S A (1972) 2.01

Opportunities for medical research in the 21st century. JAMA (2001) 2.01

Partial deletion of beta-globin gene DNA in certain patients with beta 0-thalassemia. Proc Natl Acad Sci U S A (1979) 1.94

The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. J Exp Med (1973) 1.92

The success of medicare's end-stage renal-disease program: the case for profits and the private marketplace. N Engl J Med (1981) 1.88

Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin. Science (1985) 1.86

Subtotal parathyroidectomy in chronic renal failure: a seven-year experience in a dialysis and transplant program. Ann Surg (1971) 1.83

A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83

Urine fibrinogen fragments in human renal allografts. A possible mechanism of renal injury. N Engl J Med (1968) 1.80

Antenatal diagnosis of haematological disorders--'1978'. Clin Haematol (1978) 1.78

Comparison of microsatellites and amplified fragment length polymorphism markers for parentage analysis. Mol Ecol (2000) 1.76

Survival of patients undergoing chronic hemodialysis and renal transplantation. N Engl J Med (1973) 1.74

Oxidant injury of caucasian glucose-6-phosphate dehydrogenase-deficient red blood cells by phagocytosing leukocytes during infection. J Clin Invest (1971) 1.72

Prenatal diagnosis of hemoglobinopathies. A review of 15 cases. N Engl J Med (1976) 1.69

Antenatal diagnosis of thalassaemia major. Br Med J (1978) 1.64

Human renal isografts: a clinical and pathologic analysis. Medicine (Baltimore) (1968) 1.63

Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med (1969) 1.62

Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy. Medicine (Baltimore) (1969) 1.61

Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol (1996) 1.60

Mild thalassemia: the result of interactions of alpha and beta thalassemia genes. J Clin Invest (1970) 1.59

Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera. J Exp Med (1967) 1.57

Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. N Engl J Med (1984) 1.54

Glomerulonephritis (third of three parts). N Engl J Med (1974) 1.52

Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate. Exp Hematol (1992) 1.50

Stages in the incorporation of fatty acids into red blood cells. J Clin Invest (1968) 1.49

Diamond-Blackfan anemia. Natural history and sequelae of treatment. Medicine (Baltimore) (1996) 1.46

Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood (1975) 1.46

Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med (1978) 1.45

Senescence and the renal vasculature in normal man. Circ Res (1974) 1.43

Alterations in human serum beta-1C-gobulin (C'3) in renal transplantation. Am J Med (1967) 1.42

A revived opportunity for fetal research. Nature (1993) 1.40

Reassessment of the use of desferrioxamine B in iron overload. N Engl J Med (1976) 1.40

An orally active iron chelator. N Engl J Med (1995) 1.40

Intravascular coagulation (IVC) in human renal allograft rejection. Transplant Proc (1969) 1.39

Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res (1983) 1.39

Congenital hemolytic anemia with high-sodium, low-potassium red cells. Studies of three generations of a family with a new variant. N Engl J Med (1969) 1.37

Purification of fetal hematopoietic progenitors and demonstration of recombinant multipotential colony-stimulating activity. J Clin Invest (1985) 1.36

Congenital hemolytic anemia with high sodium, low potassium red cells. I. Studies of membrane permeability. N Engl J Med (1968) 1.36

Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation. Blood (1974) 1.36

Identification and characterization of (GA/CT)n-microsatellite loci from Quercus petraea. Plant Mol Biol (1997) 1.35

Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med (1978) 1.35

Cation permeability alterations during sickling: relationship to cation composition and cellular hydration of irreversibly sickled cells. Blood (1978) 1.34

Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest (1987) 1.33

Simplified hippuran clearance. Measurement of renal function in man with simplified hippuran clearances. Nephron (1966) 1.33

Erythroid precursors in congenital hypoplastic (Diamond-Blackfan) anemia. J Clin Invest (1978) 1.33

Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med (1985) 1.30

Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest (1966) 1.30

Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicine (Baltimore) (1968) 1.28

Fetal erythropoiesis following bone marrow transplantation. Blood (1976) 1.26

Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science (1988) 1.26

Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease. J Reticuloendothel Soc (1972) 1.25

Equal synthesis of - and -globin chains in erythroid precursors in heterozygous -thalassemia. J Clin Invest (1972) 1.25

Doctor-patient communications in a private family practice. J Fam Pract (1976) 1.24

Steroid-induced ocular hypertension in patients with filtering blebs. Ophthalmology (1980) 1.23

Renal transplantation in the inbred rat. I. Morphologic, immunologic, and functional alterations during acute rejection. Transplantation (1967) 1.22

Sauna baths in the treatment of chronic renal failure. Trans Am Soc Artif Intern Organs (1966) 1.22

THE TURNOVER OF HEMOGLOBINS A, F, AND A(2) IN THE PERIPHERAL BLOOD OF THREE PATIENTS WITH THALASSEMIA. J Clin Invest (1963) 1.20

Editoral: Cardiovascular disease in dialysis patients. N Engl J Med (1974) 1.20

Uremic pericarditis. Clinical features and management. Circulation (1968) 1.20

Human renal allografts. Interpretation of morphologic and immunohistochemical observations. Am J Pathol (1968) 1.19

The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood (1997) 1.18

Hypoglossal nerve palsy in infectious mononucleosis. Neurology (1978) 1.18

Molecular analysis of the high-hemoglobin-F phenotype in Saudi Arabian sickle cell anemia. N Engl J Med (1987) 1.17

An immunosupressive site of action of heterologous antilymphocyte serum. Lancet (1967) 1.17

Beta thalassemia and translation of globin messenger RNA. Proc Natl Acad Sci U S A (1971) 1.16

Gamma-beta thalassemia: a cause of hemolytic disease of the newborn. N Engl J Med (1972) 1.16